OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of Illinois at Chicago

7 Projects | 6 Researchers | $1,122,016 Invested

2012

University of Illinois at Chicago

Mary Jo LaDu, PhD

Modulation of human apoE isoform levels as a therapeutic target using a new Alzheimer's disease transgenic mouse model

  • Funding Amount: $91,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2010

University of Illinois at Chicago

Pavel Petukhov, PhD

Mapping the Binding Site of HDAC 2 for the Design of Novel HDAC Inhibitors Lacking Zinc Binding Group

  • Funding Amount: $142,100
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Epigenetics
  • Status: Closed

2007

University of Illinois at Chicago

Alan Kozikowski, PhD

Chromatin Remodelers for Recovery of Learning and Memory

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2005

University of Illinois at Chicago

Greg Thatcher, PhD

Generation and optimization of NO mimetics for treatment of Alzheimer’s Disease

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2004

University of Illinois at Chicago

Greg Thatcher, PhD

Generation and Optimization of NO Mimetics for Treatment of Alzheimer's Disease

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2001

University of Illinois at Chicago

Duane Venton, PhD

A Combinatorial Search for Beta-Cyclodextrins to Abate the Neurotoxicity of Amyloid-Beta-Peptide in Alzheimer's Disease

  • Funding Amount: $311,916
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2001

University of Illinois at Chicago

Yanming Wang

Amyloid Probes in Aging and Alzheimer's Disease: Dual Agents for Both PET and SPECT

  • Funding Amount: $197,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed